Invention Grant
- Patent Title: Azaspiro[4.5] decane derivatives and use thereof
-
Application No.: US14914789Application Date: 2014-08-11
-
Publication No.: US09884865B2Publication Date: 2018-02-06
- Inventor: Mark A. Youngman , Laykea Tafesse , Jae Hyun Park
- Applicant: Purdue Pharma L.P.
- Applicant Address: US CT Stamford
- Assignee: Purdue Pharma L.P.
- Current Assignee: Purdue Pharma L.P.
- Current Assignee Address: US CT Stamford
- Agency: Purdue Pharma L.P.
- Agent Alan L. Koller; Weiying Yang
- International Application: PCT/US2014/050549 WO 20140811
- International Announcement: WO2015/031036 WO 20150305
- Main IPC: A61K31/435
- IPC: A61K31/435 ; A61K31/495 ; C07D471/10 ; C07D491/107
![Azaspiro[4.5] decane derivatives and use thereof](/abs-image/US/2018/02/06/US09884865B2/abs.jpg.150x150.jpg)
Abstract:
The invention provides azaspiro[4.5]decane derivatives of Formula (A): and pharmaceutically acceptable salts, solvates, hydrates, N-oxides, and diastereomers thereof, wherein A1, X, A2, Rr, R2′, W1, R3′, R4′, a, and b are defined in the disclosure. The invention also provides compounds of Formulae I, and B-G, and pharmaceutically acceptable salts, solvates, hydrates, N-oxides, and diastereomers thereof. Further, the invention provides use of the compounds of Formulae A-G and I, and the pharmaceutically acceptable salts, solvates, hydrates, N-oxides, and diastereomers thereof, to treat pain. In certain embodiments, Compounds of the Disclosure are useful for treating a disorder responsive to blockade of one or more sodium channels.
Public/Granted literature
- US20160207923A1 AZASPIRO[4.5] DECANE DERIVATIVES AND USE THEREOF Public/Granted day:2016-07-21
Information query